Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and... Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease. 詳細を表示
EDISON, N.J., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that has been developing a treatment for non-alcoholic...
EDISON, N.J., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (Nasdaq: HEPA) (the “Company” or “Hepion”), a clinical stage biopharmaceutical company that had been developing a...
Transaction Creates Opportunity to Share in Potential Upside of Pharma Two B’s Late-Clinical Stage Candidate to Treat Parkinson’s Disease Hepion’s Board Unanimously Recommends Shareholders...
KIRYAT ONO, ISRAEL and EDISON, N.J., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Pharma Two B Ltd. (“Pharma Two B”), a late-clinical stage company that is developing P2B001, an innovative combination...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.3338 | -66.9206094627 | 0.4988 | 0.5279 | 0.1348 | 554119 | 0.35372563 | CS |
4 | -0.334 | -66.9338677355 | 0.499 | 0.7345 | 0.1348 | 212603 | 0.43007244 | CS |
12 | -0.476 | -74.2589703588 | 0.641 | 0.74 | 0.1348 | 79847 | 0.47576258 | CS |
26 | -0.865 | -83.9805825243 | 1.03 | 1.03 | 0.1348 | 123479 | 0.70876109 | CS |
52 | -1.965 | -92.2535211268 | 2.13 | 3.4899 | 0.1348 | 89365 | 1.08262223 | CS |
156 | -19.461 | -99.1592785081 | 19.626 | 26.6 | 0.1348 | 210236 | 12.90859497 | CS |
260 | -110.035 | -99.8502722323 | 110.2 | 150 | 0.1348 | 906060 | 40.56704037 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約